A team of researchers from UC San Francisco, Vanderbilt University Medical School (VUMC), and Silicon Kidney are among the winners of the “KidneyX: Redesign Dialysis” prize competition for their design of an innovative, implantable hemofilter dialysis system that would enable patients to safely and effectively treat kidney failure at home.
Stanford Children's Health announced the winners of the pediatric medical device development competition hosted by the UCSF-Stanford Pediatric Device Consortium (PDC). […] In a timed, Shark Tank–style presentation, 13 finalists from a total of 74 applicants pitched their pediatric device ideas—in various stages of development—to a panel of judges.
The UCSF Rosenman Institute interviewed UCSF-Stanford PDC PI, Michael Harrison, about his career in pediatric and fetal surgery and current research in device innovation.
Few medical devices are approved specifically for babies and children. An FDA grant to fund a collaboration between Stanford and UCSF for developing pediatric devices aims to fill the gap.
Stanford Children's Health announced the winners of the pediatric medical device development competition hosted by the UCSF-Stanford Pediatric Device Consortium (PDC). […] In a timed, Shark Tank–style presentation, 13 finalists from a total of 74 applicants pitched their pediatric device ideas—in various stages of development—to a panel of judges.
Scientists, innovators, venture capitalists and medical industry experts gathered at Stanford last week for the second annual Stanford Children's Health Pediatric Innovation Showcase, a daylong event highlighting new devices and developments in pediatric medicine.
Long exam times, patient discomfort and claustrophobia are major issues in the MR suite that result in delays, failed exams and ultimately affect the bottom line. Novel printed, flexible coils could be the solution that hospitals and other MR operators are searching for to achieve good exam outcomes, increase patient satisfaction, and reduce costs.
The UCSF-Stanford Pediatric Device Consortium is funded by the U.S. Food & Drug Administration's Office of Orphan Products Development under grant no. P50FD007967.
